Detalles de la búsqueda
1.
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
Eur Heart J
; 43(31): 2984-2993, 2022 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687107
2.
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
Eur Heart J
; 42(6): 700-710, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351892
3.
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
Kidney Int
; 99(3): 750-762, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181154
4.
Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.
Circulation
; 144(15): 1265-1267, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34397263
5.
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals.
Diabetes Obes Metab
; 24(7): 1390-1393, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302277
6.
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials.
Diabetes Care
; 45(6): 1445-1452, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35472672
Resultados
1 -
6
de 6
1
Próxima >
>>